E

Edesa Biotech

18 employees

Edesa develops treatments for dermatological and anorectal diseases. Edesa merged with Stellar Biotechnologies in 2019.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
covid
biotechnology
autoimmune
Dermatology
Contact Dermatitis
inflammatory
Gastrointestinal
ARDS
Life Science

Date founded

2015

Funding rounds raised

Total raised

$7M

from 3 investors over 3 rounds

E

Edesa Biotech raised $7M on September 20, 2017

Investors: Lumira Ventures, Pharmascience and Inveready

FAQ